All Featured Insights

Health system executive leaders and boards have recently weathered numerous existential challenges, from COVID-19 to cyberattacks to the One Big Beautiful Bill.

The new generation of weight-loss drugs has the potential to help reduce prevalence of obesity and Type 2 diabetes, two of the most prevalent chronic conditions. How might that affect hospital operations and capital and financial planning?

Fierce Healthcare's Dave Muoio chats with Lisa Goldstein, senior vice president at the consulting firm Kaufman Hall, about what hospital leaders will need to focus on in the new year.

The possibility of breached covenants is a symptom of deeper problems that require an all-hands-on-deck approach to get back on a sustainable path.